Gain Therapeutics, Inc.
GANX· Nasdaq
Released Aug 8, 2022, before the open
10-Q filed Aug 8, 2022, 39 days after period end · 0001558370-22-012533
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $95.10K | $81.62K | $6.37K |
| Net Income | -$5.09M | -$3.56M | -$543.36K |
| EPS Diluted | -$0.43 | -$0.30 | -$0.27 |
Gain Therapeutics, Inc. · CIK 1819411 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.